Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC.
Saved in:
| Title: | Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC. |
|---|---|
| Authors: | Hayhow TG; Oncology R&D, AstraZeneca, Cambridge, UK. thomas.hayhow@astrazeneca.com., Williamson B; Oncology R&D, AstraZeneca, Cambridge, UK., Lawson M; Oncology R&D, AstraZeneca, Cambridge, UK., Cureton N; Oncology R&D, AstraZeneca, Cambridge, UK., Braybrooke EL; Oncology R&D, AstraZeneca, Cambridge, UK., Campbell A; Pharmaceutical Sciences, AstraZeneca, Cambridge, UK., Carbajo RJ; Oncology R&D, AstraZeneca, Cambridge, UK., Cheraghchi-Bashi A; Oncology R&D, AstraZeneca, Cambridge, UK., Chiarparin E; Oncology R&D, AstraZeneca, Cambridge, UK., Diène CR; Oncology R&D, AstraZeneca, Cambridge, UK., Fallan C; Oncology R&D, AstraZeneca, Cambridge, UK., Fisher DI; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Goldberg FW; Oncology R&D, AstraZeneca, Cambridge, UK., Hopcroft L; Oncology R&D, AstraZeneca, Cambridge, UK., Hopcroft P; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Jackson A; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Kettle JG; Oncology R&D, AstraZeneca, Cambridge, UK., Klinowska T; Oncology R&D, AstraZeneca, Cambridge, UK., Künzel U; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Lamont G; Oncology R&D, AstraZeneca, Cambridge, UK., Lewis HJ; Oncology R&D, AstraZeneca, Cambridge, UK., Maglennon G; Oncology R&D, AstraZeneca, Cambridge, UK., Martin S; Oncology R&D, AstraZeneca, Cambridge, UK., Gutierrez PM; Oncology R&D, AstraZeneca, Cambridge, UK., Morrow CJ; Oncology R&D, AstraZeneca, Cambridge, UK., Nikolaou M; Oncology R&D, AstraZeneca, Cambridge, UK., Nissink JWM; Oncology R&D, AstraZeneca, Cambridge, UK., O'Shea P; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Polanski R; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Schade M; Oncology R&D, AstraZeneca, Cambridge, UK., Scott JS; Oncology R&D, AstraZeneca, Cambridge, UK., Smith A; Oncology R&D, AstraZeneca, Cambridge, UK., Weber J; Oncology R&D, AstraZeneca, Cambridge, UK., Wilson J; Oncology R&D, AstraZeneca, Cambridge, UK., Yang B; Oncology R&D, AstraZeneca, Waltham, MA, USA., Crafter C; Oncology R&D, AstraZeneca, Cambridge, UK. |
| Source: | Communications biology [Commun Biol] 2024 May 13; Vol. 7 (1), pp. 563. Date of Electronic Publication: 2024 May 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38740899 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hayhow+TG%22">Hayhow TG</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK. thomas.hayhow@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Williamson+B%22">Williamson B</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Lawson+M%22">Lawson M</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Cureton+N%22">Cureton N</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Braybrooke+EL%22">Braybrooke EL</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Campbell+A%22">Campbell A</searchLink>; Pharmaceutical Sciences, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Carbajo+RJ%22">Carbajo RJ</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Cheraghchi-Bashi+A%22">Cheraghchi-Bashi A</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Chiarparin+E%22">Chiarparin E</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Diène+CR%22">Diène CR</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Fallan+C%22">Fallan C</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Fisher+DI%22">Fisher DI</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Goldberg+FW%22">Goldberg FW</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Hopcroft+L%22">Hopcroft L</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Hopcroft+P%22">Hopcroft P</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Jackson+A%22">Jackson A</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kettle+JG%22">Kettle JG</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Klinowska+T%22">Klinowska T</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Künzel+U%22">Künzel U</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Lamont+G%22">Lamont G</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Lewis+HJ%22">Lewis HJ</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Maglennon+G%22">Maglennon G</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Martin+S%22">Martin S</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Gutierrez+PM%22">Gutierrez PM</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Morrow+CJ%22">Morrow CJ</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Nikolaou+M%22">Nikolaou M</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Nissink+JWM%22">Nissink JWM</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22O'Shea+P%22">O'Shea P</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Polanski+R%22">Polanski R</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Schade+M%22">Schade M</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Scott+JS%22">Scott JS</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Smith+A%22">Smith A</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Weber+J%22">Weber J</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Wilson+J%22">Wilson J</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Yang+B%22">Yang B</searchLink>; Oncology R&D, AstraZeneca, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Crafter+C%22">Crafter C</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101719179%22">Communications biology</searchLink> [Commun Biol] 2024 May 13; Vol. 7 (1), pp. 563. <i>Date of Electronic Publication: </i>2024 May 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+UK%22">Nature Publishing Group UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101719179 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2399-3642 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223993642%22">23993642 </searchLink><i>NLM ISO Abbreviation: </i>Commun Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38740899 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s42003-024-06238-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 563 Titles: – TitleFull: Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hayhow TG – PersonEntity: Name: NameFull: Williamson B – PersonEntity: Name: NameFull: Lawson M – PersonEntity: Name: NameFull: Cureton N – PersonEntity: Name: NameFull: Braybrooke EL – PersonEntity: Name: NameFull: Campbell A – PersonEntity: Name: NameFull: Carbajo RJ – PersonEntity: Name: NameFull: Cheraghchi-Bashi A – PersonEntity: Name: NameFull: Chiarparin E – PersonEntity: Name: NameFull: Diène CR – PersonEntity: Name: NameFull: Fallan C – PersonEntity: Name: NameFull: Fisher DI – PersonEntity: Name: NameFull: Goldberg FW – PersonEntity: Name: NameFull: Hopcroft L – PersonEntity: Name: NameFull: Hopcroft P – PersonEntity: Name: NameFull: Jackson A – PersonEntity: Name: NameFull: Kettle JG – PersonEntity: Name: NameFull: Klinowska T – PersonEntity: Name: NameFull: Künzel U – PersonEntity: Name: NameFull: Lamont G – PersonEntity: Name: NameFull: Lewis HJ – PersonEntity: Name: NameFull: Maglennon G – PersonEntity: Name: NameFull: Martin S – PersonEntity: Name: NameFull: Gutierrez PM – PersonEntity: Name: NameFull: Morrow CJ – PersonEntity: Name: NameFull: Nikolaou M – PersonEntity: Name: NameFull: Nissink JWM – PersonEntity: Name: NameFull: O'Shea P – PersonEntity: Name: NameFull: Polanski R – PersonEntity: Name: NameFull: Schade M – PersonEntity: Name: NameFull: Scott JS – PersonEntity: Name: NameFull: Smith A – PersonEntity: Name: NameFull: Weber J – PersonEntity: Name: NameFull: Wilson J – PersonEntity: Name: NameFull: Yang B – PersonEntity: Name: NameFull: Crafter C IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 05 Text: 2024 May 13 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2399-3642 Numbering: – Type: volume Value: 7 – Type: issue Value: 1 Titles: – TitleFull: Communications biology Type: main |
| ResultId | 1 |